Genix Pharmaceuticals Corporation
GENPF
Get informed when a big investor buys or sells
+ FollowMarket Cap$844.89K
Close$
Share Statistics
| Market cap | $844,893.00 |
|---|---|
| Enterprise Value | $1.60 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.01 |
| Beta | 0.4 |
| Outstanding Shares | 61,224,131 |
Return
| Return on Equity | 18.25% |
|---|---|
| Return on Assets | -847.70% |
| Return on Invested Capital | 7.49% |
Valuation & Multiples
| P/E Ratio | -5.18 |
|---|---|
| PEG | -10.19 |
| Price to Sales | - |
| Price to Book Ratio | -0.01 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -13.82 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.48 |
| Debt to Equity | -0.5 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
October 8, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
October 13, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Genix Pharmaceuticals Corporation
4,000 employees
CEO: Sina Salehi Pirooz Genix Pharmaceuticals Corporation, established in 1993 and headquartered in Vancouver, Canada, is actively involved in the creation, production, licensing, and distribution of various life science products. The company's primary focus in...